Eiken

  • Site Map
  • Contact Us
  • En|Jp
  • About Eiken
  • Products
  • Our Fields
  • Publication
  • Investor Relations
  • Research and Development
  • Sustainability

About Us

About Us

  • Message from the CEO
  • Our Management Philosophy
  • Brand Story
  • Our Business
  • Company Profile
  • Offices/Group Company
  • Executives
  • Eiken's History
  • Management Plan
  • PR Videos

Products

Products

  • Fecal Testing "OC-SENSOR"
  • Molecular Test “LAMP”
  • Immunological and Serological Reagents “LZ Test Eiken”
  • Veterinary “VET-SAA Eiken”

Our Fields

Our Fields

  • Gastroenterology
  • Infectious diseases
  • Veterinary

Publication

Publication

  • Fecal Immunochemical Test
  • Gastric Cancer Risk Assessment Test (ABCD risk classification)
  • Veterinary
  • Molecular Test "LAMP"

Investor Relations

Investor Relations

  • Message form the CEO
  • Management Plan
  • Financial Data or Financial Highlites
  • IR Library
  • Stakeholder Message
  • Stock Information
  • IR Calender
  • IR News
  • IR Policy
  • Operating Risks

Research and Development

Research and Development

  • R&D Vision
  • EIKEN’s Technologies
  • R&D Structure
  • Intellectual Property

Sustainability

Sustainability

  • CEO Message
  • Eiken and Sustainability
  • ESG Data
  • Integrated Report
  • Stakeholder Message
  • External Evaluation

Medical

  • Improving Access to Healthcare
  • Solutions to Medical Issues
  • Pursuing Quality and Establishing Sustainable Supply Chains

Environment

  • Environmental Management
  • Responding to Climate Change
  • Contributing to a Recycling-Oriented Society

Social

  • Respecting Human Rights and Diversity
  • Employee Engagement and Personnel Training
  • Boosting Health and Ensuring Safety and Hygiene

Governance

  • Achieving Transparent and Sound Governance
  • Rigorous Compliance and Thorough Corruption Prevention
  • Establishing Risk Management
  • En
  • Jp

News

  1. TOP
  2. News

Year:

Category:

SubCategory:

  • 2025.07.01 CorporateSR, IR, ReleaseNotice Concerning the Progress of the Acquisition of Treasury Shares
  • 2025.06.25 CorporateSR, IR, ReleaseAnnual Securities Report
  • 2025.06.25 CorporateSR, IR, ReleaseNotice of Resolution of the 87th Ordinary General Meeting of Shareholders
  • 2025.06.24 CorporateSR, IR, ReleaseNotice Concerning Partial Amendment of Articles of Incorporation
  • 2025.06.24 CorporateIR, ReleaseNotice Regarding Disposal of Treasury Shares as Restricted Stock Compensation
  • 2025.06.09 CorporateIR, ReleaseThe Company Certified as a Co-creator for TICAD 9
  • 2025.06.04 CorporateSRNotice of Partial Correction to the “NOTICE OF CONVOCATION OF THE 87th GENERAL MEETING OF SHAREHOLDERS”
  • 2025.06.02 CorporateIR, ReleaseNotice Concerning the Progress of the Acquisition of Treasury Shares
  • 2025.06.02 CorporateRelease, SRNOTICE OF CONVOCATION OF THE 87th GENERAL MEETING OF SHAREHOLDERS

prev

  • 1
  • 2
  • 3

next

  • Contact us
  • News
  • Site Map
  • Term of Use
  • Privacy Policy

Copyright(C) Eiken Chemical Co., Ltd. All Rights Reserved.

Eiken

We use cookies to improve your online experience of this website.
If you continue to browse without changing your settings, we will assume that you are agreeing to our use of cookies.
You can also click the "Agree" button to accept our policy, then this message does not appear in the future.
Full details are in our Privacy Policy.

Agree